Skip to content

A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection

A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06168669
Enrollment
222
Registered
2023-12-13
Start date
2023-03-11
Completion date
2025-09-29
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Leak, Colorectal Surgery

Brief summary

Purpose: To validate the safety and effectiveness of xBar monitoring tool for detection of post-operative anastomotic leaks in subjects undergoing rectal/sigmoid resections with anastomosis. The clinical team is blinded to the leak detection of the xBar system.

Detailed description

Study design: Pivotal, Prospective, Blinded, multi-center study. Study Population: This study will enroll approximately 190 eligible subjects undergoing scheduled colorectal surgery with anastomosis, without concomitant diversion. xBar is an investigational device intended for post-op monitoring of patients undergoing GI surgery. The device is comprised of a surgical drain with embedded electrodes, connected to a small electronic device that records and relays data from the electrodes. The collected data is processed for early detection of complications. Study description: The study is intended to validate the performance of the xBar system's anastomotic leak detection monitoring tool following colorectal resection with drain placement. During the index surgery the xBar device will be placed according to institution standard procedures and data recording will commence for a period of at least 3 days. Safety and complication detection performance will be evaluated retrospectively by comparing the diagnosis on a subject level done by the clinical team, who is blinded to xBar results, and the system.

Interventions

DIAGNOSTIC_TESTxBar system

xBar system is surgical drain with embedded sensors. Collected data will be evaluated for an ability to identify anastomotic leaks. The xBar system does not have therapeutic indication.

Sponsors

Exero Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

Investigators, clinical teams and subjects will be blinded to the outcomes provided by xBar system. Post operative monitoring will be as per SOC.

Intervention model description

All eligible subjects will be assigned with the investigational device.

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 22 years 2. Indication for sigmoid or rectal resection surgery. 3. Usage of drain during the surgery (to be confirmed during the surgery) 4. Willing and able to comply with the study follow up. 5. Able and agree to provide an informed consent.

Exclusion criteria

1. Contraindication for surgery and/or general anesthesia. 2. Pregnancy or lactation. 3. Planned or unplanned fecal diversion during the surgery (to be confirmed during the surgery) 4. Known electronic device implanted in the chest or the abdominal cavity (e.g., pacemaker, cardioverter/defibrillator). 5. Major medical or psychiatric illness or condition, or other factors that may affect general health or ability to adhere to the follow-up schedule. 6. Known allergic reactions to materials used in the components of the xBar system, i.e., silicone, rubber and stainless-steel. 7. Participation in another interventional study during the xBar system usage.

Design outcomes

Primary

MeasureTime frameDescription
Safetythrough study completion, an average of 1 yearIncidence of Unanticipated Serious Adverse Events Related to the xBar System or xBar Procedure
Safety - Severe leak rate - comparable to SOC.through study completion, an average of 1 yearIncidence of Severe Anastomotic Leak. Statistical evaluation of prevalence of anastomotic leaks in the study group compared to the prevalence present in the literature.
Performance - xBar Technical Success Ratethrough study completion, an average of 1 yearxBar Technical Success Rate

Secondary

MeasureTime frameDescription
SensitivityFrom the xBar placement up to POD3Sensitivity of xBar for Detection of Severe Anastomotic Leak assuming is non-inferior compared to Standard of care at POD 3
Specificityfrom the xBar placement up to post operative day 3Specificity of xBar for Detection of Severe Anastomotic Leak assuming is non -inferior to standard of care detection

Countries

Israel, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026